Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-20

Clinical Trial Update: Oral Melatonin VS Nebulized Dexmedetomidine Premedication on Attenuation of Hemodynamic Response to Direct Laryngoscopy and Tracheal Intubation in Hypertensive Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial comparing oral melatonin to nebulized dexmedetomidine as premedication to attenuate hemodynamic responses during direct laryngoscopy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Melatonin (melatonin)

Snippet

Sponsor: Tanta University | Conditions: Tracheal Intubation Morbidity, Laryngoscopy | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING